Tops & Flops Stocks
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aspira Womens Health Inc. | 0.850% | -11.278% | -26.708% | -41.728% | -41.728% | -96.440% | -85.337% |
| Assembly Biosciences Inc. | 3.990% | - | - | - | - | - | - |
| Atara Biotherapeutics Inc. | 10.880% | 15.510% | -5.758% | -69.415% | 16.641% | -94.921% | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Avalo Therapeutics Inc. | 2.500% | - | - | - | - | - | - |
| Avenue Therapeutics Inc. | 22.820% | - | - | - | - | - | - |
| Aveo Pharmaceuticals Inc. | -1.910% | - | - | - | - | - | - |
| Avid Bioservices Inc | - | 2.454% | 40.336% | -38.148% | 36.885% | -48.457% | 175.532% |
| Axsome Therapeutics Inc | -0.330% | 2.281% | 12.516% | 2.369% | -0.195% | 57.913% | - |
| Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
| Biocryst Pharmaceuticals | -1.730% | 8.652% | 36.344% | -27.287% | 2.566% | -50.298% | -14.065% |
| Biodelivery Sciences | -0.980% | - | - | - | - | - | - |
| Biolife Solutions Inc | - | 5.820% | 37.931% | 2.041% | 34.228% | -24.414% | 23.962% |
| Biospecifics Techs | -0.680% | - | - | - | - | - | - |
| Brainstorm Cell | 17.130% | 0.400% | -1.375% | -82.199% | 116.379% | -82.448% | - |
| Calithera Biosciences Inc. | - | - | - | - | - | - | - |
| Capricor Therapeutics Inc | 0.350% | 13.917% | 22.045% | 36.918% | 28.045% | 80.189% | - |
| Cara Therapeutics Inc. | -6.810% | 3.678% | 16.349% | -79.129% | 5.696% | -93.342% | -95.611% |
| Caredx Inc | 0.870% | 3.170% | 88.719% | 98.889% | 23.448% | -75.729% | - |
| Carisma Therapeutics Inc. | -0.620% | -13.200% | -20.254% | -89.316% | -54.161% | -97.287% | -97.827% |
| CASI Pharmaceuticals Inc. | -1.850% | - | - | - | - | - | - |
| Catalyst Pharmaceutical Partners Inc | -0.360% | 0.931% | 3.866% | 34.813% | -2.317% | 230.575% | 325.687% |
| Champions Oncology Inc | -0.930% | -3.620% | -8.584% | 0.000% | -11.618% | -44.675% | - |
| Checkpoint Therapeutics | - | - | - | - | - | - | - |
| Chembio Diagnostics Inc. | - | - | - | - | - | - | - |